Scroll To Top
Features

A Setback for the World's Women

A Setback for the World's Women

Woman_worried_0

Researchers working to develop a new HIV prevention tool for the world's women had their hopes shattered when data from a final Phase III human trial of the vaginal microbicide gel Carraguard showed it failed to prevent HIV infections among the more than 6,200 women studied. HIV incidence was only slightly lower among the women using the gel than among those given a placebo. And women used the compound less than half the time they had sex, a rate far lower than expected. 'Even a highly efficacious coitally dependent product will have insufficient effectiveness in real-life settings,' the researchers disappointedly wrote in The Lancet.

Advocate Channel - The Pride StoreOut Magazine - Fellow Travelers

From our Sponsors

Most Popular

Latest Stories

HIV Plus Editors

Editor

Ryan is the Digital Director of The Advocate Channel, and a graduate of NYU Tisch's Department of Dramatic Writing. She is also a member of GALECA, the LGBTQ+ society of entertainment critics. While her specialties are television writing and comedy, Ryan is a young member of the LGBTQ+ community passionate about politics and advocating for all.

Ryan is the Digital Director of The Advocate Channel, and a graduate of NYU Tisch's Department of Dramatic Writing. She is also a member of GALECA, the LGBTQ+ society of entertainment critics. While her specialties are television writing and comedy, Ryan is a young member of the LGBTQ+ community passionate about politics and advocating for all.